Eruptive latent metastatic melanomas after initiation of antitumor necrosis factor therapies - 12/08/11
Hershey, Pennsylvania
Abstract |
We report two cases of late recurrence of eruptive locoregional metastatic melanoma occurring 6 and 9 years after definitive surgical treatment. Each case (stage IB and IA) occurred after initiation of the subcutaneous anti-tumor necrosis factor medications etanercept and adalimumab, respectively. We discuss the association of immune suppression and melanoma. These cases illustrate a previously unrecognized and potentially causal relationship between tumor necrosis factor-⍺ inhibition and reactivation of latent melanoma.
Le texte complet de cet article est disponible en PDF.Plan
Funding sources: None. Conflicts of interest: None declared. |
Vol 56 - N° 5S
P. S65-S67 - mai 2007 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?